|
PSMA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
2.98809999965677E-07 |
| Normal-vs-Stage3 |
1.06689990175823E-10 |
| Normal-vs-Stage4 |
6.23279206024563E-13 |
| Stage1-vs-Stage2 |
5.431600E-01 |
| Stage1-vs-Stage3 |
5.982000E-01 |
| Stage1-vs-Stage4 |
3.837300E-03 |
| Stage2-vs-Stage3 |
8.585000E-01 |
| Stage2-vs-Stage4 |
1.037830E-01 |
| Stage3-vs-Stage4 |
3.158000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
7.82219999995171E-07 |
| Normal-vs-Asian |
2.804200E-02 |
| Caucasian-vs-AfricanAmerican |
1.251710E-02 |
| Caucasian-vs-Asian |
3.874600E-01 |
| AfricanAmerican-vs-Asian |
2.180800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.11022302462516E-16 |
| Male-vs-Female |
7.843200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.141250E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.675500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.163600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.120200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.891800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.887200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.874600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.070000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.35620000177406E-08 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
4.25215418431435E-14 |
| Normal-vs-Grade 4 |
8.09279976365929E-10 |
| Grade 1-vs-Grade 2 |
2.149600E-01 |
| Grade 1-vs-Grade 3 |
8.957800E-01 |
| Grade 1-vs-Grade 4 |
5.090300E-02 |
| Grade 2-vs-Grade 3 |
1.056830E-01 |
| Grade 2-vs-Grade 4 |
2.010200E-01 |
| Grade 3-vs-Grade 4 |
3.278300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
8.28226376370367E-14 |
| ccA subtype-vs-ccB subtype |
8.127200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62436730732907E-12 |
| Normal-vs-N1 |
3.659500E-03 |
| N0-vs-N1 |
2.879800E-01 |
|
|
